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Aggressive attempts at limb salvage in patients
who have ischemic tissue loss as the result of severe
infrainguinal arterial occlusive disease have been jus-
tified by the favorable results of infrainguinal bypass
grafting.1-4 Furthermore, limb salvage provides the
best chance for the patient to maintain ambulatory
status and living condition,5,6 and long-term survival
rates after successful bypass grafting are significantly
greater than after amputations.1,7 However, patients
in whom attempted limb salvage is unsuccessful sus-
tain the risks and costs of the bypass grafting proce-
dure without any benefit, although the level of the
subsequent amputation is usually not affected by the
failure of the attempted bypass grafting.4
The identification of patients with ischemic tissue
loss and severe infrainguinal arterial occlusive disease
who will not benefit from attempted revascularization
remains difficult. Primary amputation is obviously
indicated for patients who are bedridden, who have
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Purpose: Aggressive attempts at limb salvage in patients with ischemic tissue loss are jus-
tified by favorable initial results in most patients. The identification of patients whose
conditions will not benefit from attempted revascularization remains difficult.
Methods: This study was designed as a retrospective review of prospectively collected clini-
cal data. The subjects were 210 consecutive patients who underwent infrainguinal vein
bypass grafting for ischemic tissue loss in the setting of an academic medical center. Bypass
grafting was to the popliteal artery in 56 patients, to the infrapopliteal arteries in 131
patients, and to the pedal arteries in 23 patients. The follow-up examination was complete
in 209 of 210 patients. One hundred twenty-five patients underwent blinded review of
duplex scan venous mapping and arteriography to determine simplified vein and run-off
scores. The outcome measures were the influence of risk factors, venous conduit, and
runoff on mortality, limb loss, and graft failure at the 6-month follow-up examination.
Results: One hundred seventy patients (81%) were alive and had limb salvage. Nineteen
patients (9.1%) died, with need for a simultaneous inflow procedure and end-stage renal
disease being most commonly associated with mortality. Thirty-three patients (15.8%)
had undergone amputation: 18 after graft failure, and 15 for progressive tissue loss
despite a patent graft. Amputation was significantly more common in patients with dia-
betes (P = .05) and with poor runoff scores (poor runoff, 44.4% vs good runoff, 7.4%;
P < .01). Amputation despite a patent graft also correlated with runoff (poor runoff,
41.7% vs good runoff, 4.3%; P < .01). Twenty-five patients had graft failure without
amputation, so that only 145 patients (69.4%) were alive, had limb salvage, and had a
patent graft. Run-off score was the strongest predictor of outcome, with 70% of patients
with poor run-off scores having death, amputation, or graft failure.
Conclusion: Aggressive use of infrainguinal vein bypass grafting in patients with ischemic
tissue loss results in a high rate of initial limb salvage but significant morbidity and mor-
tality. Arteriographically determined runoff scores appear to potentially identify patients
at high risk for a poor initial outcome and may provide a method of selecting patients
for primary amputation. (J Vasc Surg 1999;30:427-35.)
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severe neurologic impairment, or in whom sepsis or
gangrene make foot salvage impossible. Primary
amputation may also be appropriate in selected
patients who are institutionalized or non-ambulatory
with ischemic tissue loss because of poor long-term
survival and functional outcome after revasculariza-
tion procedures.5 Arterial reconstructive procedures
are performed if possible in the remainder of patients
with ischemic tissue loss, with reported operative
mortality rate associated with infrainguinal bypass
grafting being 2% to 8%,1,7 initial limb salvage rate
being 91% to 97%,4,8 and initial bypass graft patency
rate being 85% to 95%.5,9 Thus, potentially 10% to
32% of patients who agree to undergo an infrainguinal
bypass grafting procedure, do not achieve their goal
of survival, limb salvage, and hemodynamic improve-
ment in the affected extremity.
To determine the incidence rate of a “bad” out-
come as defined by these patient-specific parameters,
we reviewed a large group of patients who under-
went infrainguinal vein bypass grafting for ischemic
tissue loss at a single institution. We also investigat-
ed factors that were potentially associated with early
graft failure and limb loss in an attempt to identify
predictors of poor outcome and subsets of patients
who were likely to have less than optimal results.
MATERIALS AND METHODS
Patients and clinical procedures. The records
of 210 consecutive patients who underwent infrain-
guinal vein bypass grafting for ischemic tissue loss
between January 1984 and December 1994 were
reviewed. The patients with neuropathic ulcers and no
evidence of ischemia were excluded from this review.
These patients represented 33% of the patients who
underwent infrainguinal bypass grafting at the Shands
Hospital at the University of Florida and the
Gainesville Veterans Affairs Hospital during this time
period. All the patients with ischemic tissue loss were
considered for arterial reconstruction, except for
those who had foot sepsis or tissue loss to such a
degree that foot salvage was precluded and those who
were irrevocably non-ambulatory. Thus, all the
patients who were included in this review were ambu-
latory or had been ambulatory immediately before
the development of the ischemic lesion, and sufficient
viable foot tissue was deemed present for healing and
limb salvage with successful revascularization. All the
patients underwent a routine preoperative evaluation
that included a history and a physical examination, 
a chest x-ray, an electrocardiogram, an echocardio-
gram, blood work, ankle brachial and toe brachial sys-
tolic pressure indices, and selective cardiac testing.
Ischemic tissue loss was confirmed by the presence of
an ankle brachial systolic pressure index of less than
0.40, a toe brachial systolic pressure index of less than
0.30, or the failure of healing of a lesion that appeared
ischemic after at least 4 weeks of local therapy.
Ischemic wounds were cultured, and patients under-
went treatment with appropriate antibiotics before
and after the vascular reconstruction. Nonviable tissue
was debrided either before or at the time of the recon-
structive procedure, depending on the degree of sep-
sis present, and during the postoperative period as
appropriate. Hyperbaric oxygen therapy was used
selectively in these patients.
Preoperative arteriography of the aorta and the
run-off vessels using iodinated or CO2 gas contrast
with both cut film and digital subtraction techniques
(DSA) was performed in all the patients. CO2 gas
was only used in those patients with contrast allergy
or renal insufficiency. Studies were performed with
either a Philips Integris 3000 (Philips Medical
Systems, North American Co, Atlanta, Ga) with a
1024 matrix DSA unit or a Toshiba Angiorex KXO
2050 (Toshiba American Medical Systems, Tustin,
Calif) with a 1024 matrix DSA unit. The contrast
injection was performed with 3F or 4F pigtail (Omni
Flush, AngioDynamics, E-Z-EM, Queensbury, NY)
or selective catheters. The flow rates for iodinated
contrast ranged from 7 to 12 mL/s for 2 to 4 sec-
onds for aortic injections to 4 to 5 mL/s for 4 to 5
seconds for external iliac artery injections. CO2 gas
was injected either manually or with a power injector,
with volumes of 60 mL for aortic injections and 40
mL for external iliac artery injections. Whenever 
tibial or pedal vessels failed to opacify, injection
catheters were positioned more distally and contrast
delivery was augmented with intra-arterial injection
of vasodilators (nitroglycerin, 100 m g) and elevation
of the legs when CO2 gas contrast was used. Imaging
was continued until the distal vessels were opacified
and began to fade, tiny unnamed vessels opacified, or
a soft tissue blush had appeared. Preoperative
extremity vein mapping of the lower and upper
extremities with duplex ultrasound scanning was also
performed in all the patients.
The bypass grafting procedures were performed
with either general inhalation or epidural anesthesia
and standard vascular surgical techniques. The bypass
grafts were constructed with greater saphenous,
lessor saphenous, and arm veins that were more than
2.5 mm in diameter with preoperative duplex scan
mapping, placed most commonly in a nonreversed
configuration. Intraoperative, pre–bypass grafting
arteriography was used extensively to aid in the selec-
tion of the ideal distal target for the bypass graft,10
and completion arteriography or video angioscopy
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was performed to assess the technical adequacy of all
bypass grafts and to exclude vein segments that con-
tained areas of sclerosis from use as bypass graft con-
duit. Cut-film, intraoperative, pre–bypass grafting
arteriograms were performed by means of insertion
under direct vision of a 21-gauge needle into the
artery chosen as the distal bypass graft target from
the preoperative arteriogram and by positioning an x-
ray plate below the injection site to cover the entire
run-off bed, including the foot. The x-ray plate was
then exposed with a portable x-ray machine, after the
injection of 10 to 15 mL of iodinated contrast. All
the patients were administered 325 mg of aspirin per
day beginning on postoperative day 1, and postoper-
ative anticoagulation therapy (heparin beginning 12
to 48 hours after surgery followed by long-term anti-
coagulation therapy with warfarin) was used for indi-
cations that have been previously identified.11 Bypass
graft patency was confirmed at hospital discharge
with a palpable graft pulse or palpable pedal pulses
that were not present before the bypass grafting pro-
cedure plus an increase in the ankle brachial systolic
pressure index in the affected extremity by 0.20 or
more or duplex ultrasound scan graft imaging.
Follow-up and data collection. The patients
were seen in the outpatient clinic after hospital dis-
charge at 2 weeks, 1 month, 3 months, and 6 months.
For the purpose of this study, the follow-up period
was terminated at that point, although our clinical
practice is to follow each patient every 6 months
thereafter for as long as the bypass graft is patent.
Graft patency was confirmed at each clinic visit after
the initial visit as described previously. The patients
who had a decrease in their ankle brachial indices of
0.15 as compared with the discharge value or who
had a duplex ultrasound graft scan examination that
showed localized velocities of more than 180 cm/s or
less than 30 cm/s were considered to have a failing
graft and underwent contrast arteriography. Graft
stenoses >50% were repaired surgically, as were signif-
icant lesions in the inflow and run-off arteries.
Follow-up examination was complete in 209 of
the 210 patients. Patient demographics (age, sex),
comorbidities (diabetes mellitus, hypertension, coro-
nary artery disease, cerebrovascular disease, end-
stage renal disease, smoking history, previous arterial
procedures), the extent of tissue loss, operative pro-
cedures, operative outcomes, and follow-up data
were obtained from a review of prospectively collect-
ed preoperative data sheets, clinic charts, and com-
plete medical records. Bypass graft levels were deter-
mined from a review of the dictated operative record
and classified as popliteal, tibial, peroneal, and pedal.
Bypass graft level then was further categorized as
“good” (popliteal and tibial) or “bad” (peroneal and
pedal) to investigate the influence of collateral foot
perfusion (peroneal bypass grafts) or a limited run-
off bed (pedal bypass grafts) on outcome. Tissue loss
was classified as limited (ischemic ulceration <5 cm in
diameter or gangrene confined to the toes without
forefoot sepsis) or extensive. Complications were
defined with the National Veterans Affairs Surgical
Quality Improvement Program criteria.12 Operative
mortality rates were defined as in-hospital or 30-day
mortality, and limb salvage and graft patency rates
were determined from recorded results of physical
examination, noninvasive vascular testing, and arteri-
ograms. The data are presented and analyzed with
the standards recommended by Rutherford et al.13
A subset of 125 patients whose complete preoper-
ative venous mapping studies and preoperative and
intraoperative contrast arteriograms were available also
underwent blinded review to determine the influence
of the quality of the venous conduit used for each
bypass graft and the run-off arteries distal to the bypass
graft on outcome. Demographics, comorbidities,
bypass grafting procedures performed, and outcomes
were similar in these 125 patients as compared with the
entire group of 210 patients (P > .05, for all compar-
isons). Venous conduit was classified as greater saphe-
nous vein more than 3 mm in diameter, alternative
(arm or lessor saphenous vein) or composite vein more
than 3 mm in diameter, greater saphenous vein less
than 3 mm in diameter, and alternative or composite
vein less than 3 mm in diameter, with a scale from 1 to
4, respectively. The vein scores were then categorized
into “good” (scores 1 and 2) and “bad” (scores 3 and
4) to also investigate the effect of vein size on out-
come. Run-off was classified from review of both pre-
operative and intraoperative arteriograms with a mod-
ification of the grading system proposed by Rutherford
et al13 (Fig 1). All the bypass grafts were performed to
infrapopliteal, pedal, or below-knee popliteal arteries
with single infrapopliteal vessel runoff. The site of the
distal anastomosis of the bypass graft and the run-off
artery in the calf were classified as <50% stenotic (grade
1) or >50% stenotic (grade 2). The run-off arteries at
the ankle and those in the foot were classified as
direct/named (grade 1) or collateral (grade 2). Thus,
the run-off scores for bypass grafts to popliteal or
infrapopliteal arteries could range from 4 to 8 and for
bypass grafts to pedal arteries could range from 3 to 6.
The run-off scores were then further categorized as
“good” (scores ≤6 for popliteal and infrapopliteal
bypass grafts and ≤5 for pedal bypass grafts) or “bad”
(scores >6 for popliteal and infrapopliteal bypass grafts
and >5 for pedal bypass grafts).
Statistical analysis. Postoperative and 6-month
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outcomes were compared with comorbidities, extent
of tissue loss, bypass graft levels (individual and cat-
egorized), and vein and run-off scores (continuous
and categorized) with nonpaired Student t test, c 2
test, and Fisher exact test where appropriate. The
outcomes that were investigated were mortality,
amputation, bypass graft patency, survival with limb
salvage, and survival with limb salvage and graft
patency. The predictors of outcome with univarient
analysis then were analyzed with multiple logistic
regression analysis to determine the independent
predictors of individual outcomes. Statistical analysis
was done with the SPSS version 6.1 statistical soft-
ware package (SPSS Inc, Chicago, Ill). The results
are presented as the mean plus the standard devia-
tion for continuous data, and P values of less than
.05 were considered significant.
RESULTS
The patients who underwent infrainguinal bypass
graft placement for tissue loss were mostly male smok-
ers, approximately 60 years of age, who had diabetes
mellitus (20% of whom had end-stage renal disease),
hypertension, and a history of coronary artery disease
(Table I). Furthermore, one half of these patients had
previously undergone a procedure for peripheral arte-
rial occlusive disease (either a reconstruction or an
amputation), and one fifth had end-stage renal disease
(70% of whom had diabetes mellitus). Bypass grafting
was to the below-knee popliteal artery in 56 patients,
to the infrapopliteal arteries in 131 patients (posterior
tibial, n = 56; anterior tibial, n = 38; peroneal, n = 37),
and to the pedal arteries in 23 patients (dorsalis pedis
in all). Simultaneous inflow procedures for repair of
aortoiliac arterial occlusive disease were performed in
28 patients (aortobifemoral bypass grafting in 14,
extra-anatomic or iliofemoral bypass grafting in 14).
Conduit used for the bypass graft was greater saphe-
nous vein in 173 patients (non-reversed in 142, in situ
in 29, and reversed in 2), composite greater saphenous
vein in 17 patients, composite arm vein in 16 patients,
and composite greater saphenous and arm vein in four
patients. Completion study results (angiography or
angioscopy) revealed abnormalities in 20 patients, all
of which were corrected. Postoperative anticoagula-
tion therapy with heparin and warfarin was used in 66
patients (31%). Poor run-off (“bad” run-off score) was
present in 20.4% of patients, and marginal venous con-
duit (“bad” vein score) was used in 10.3% of bypass
grafting procedures (in the subset of patients in whom
run-off and vein scores were reviewed).
Death occurred in 19 patients—17 after surgery
(operative mortality rate, 8.1%), and two during the
follow-up period. Cardiac complications accounted
for 13 of the deaths (68%): 12 during the postopera-
tive period, and one after hospital discharge. The
remaining deaths were caused by respiratory failure
in two patients, stroke in one patient, and sepsis in
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Fig 1. Method by which run-off scores were calculated. Total run-off scores for bypass grafts
to popliteal or infrapopliteal arteries could range from 4 to 8 and for bypass grafts to pedal
arteries could range from 3 to 6.
Table I. Characteristics of patients with tissue loss
who undergo infrainguinal vein bypass grafting 
(n = 210)
Patient characteristics
Age (years) 62.2 ± 11.5
Male 79%
Diabetes mellitus 67%
End-stage renal disease 21%
Hypertension 67%
Coronary artery disease 52%
Cerebral vascular disease 23%
Smoking 87% (44% currently)
Previous vascular procedure 50%
one patient (after hospital discharge), and two
patients died after they decided to stop dialysis after
long and difficult postoperative courses. The factors
that were most commonly associated with postoper-
ative mortality were end-stage renal disease (present
in nine patients [53%]) and use of a simultaneous
inflow procedure (present in five patients [26%]).
Indeed, the postoperative mortality rate was 22.5% in
patients with end-stage renal disease and 17.2% in
patients who underwent an inflow procedure in addi-
tion to infrainguinal bypass grafting as compared
with only 5.5% in those patients without end-stage
renal disease (P < .05) and 6.6% in those patients
who underwent infrainguinal bypass grafting alone
(P = .2). Furthermore, the mortality rate was 28.6%
in those patients who underwent aortobifemoral
bypass grafting for simultaneous repair of the inflow
disease as compared with 7.1% in those patients who
had extra-anatomic or iliofemoral bypass grafts. Only
three deaths occurred after unsuccessful bypass graft-
ing procedures that led to amputations (one necessi-
tated by graft failure after an arteriogram for symp-
toms in the contralateral leg during the follow-up
period, and two by progressive tissue necrosis despite
a patent graft), and the postoperative mortality rate
after amputation was 9.1% (vs a 9.1% mortality rate
in the patients who did not require amputations).
Forty-six graft failures occurred in 45 patients
(21.4%): 19 in the postoperative period, and 27 dur-
ing the first 6 months of the follow-up period after
hospital discharge. One graft that was revised after
failure during the postoperative period failed again
during the follow-up period. Graft disruption as the
result of wound breakdown and graft exposure was
the most common cause of graft failure during the
postoperative period, and graft stenosis was the most
common cause of graft failure during the follow-up
period (Table II). Breakdown of a pedal wound
resulting in graft exposure led to graft disruption in
five of eight patients with this problem, and 62.5%
of these patients had diabetes mellitus. The bypass
graft conduit was saphenous vein in 39 of the grafts
that failed (14 of 19 postoperative failures and 25 of
27 failures during the follow-up period) and com-
posite vein in seven. The bypass grafts that failed
were to the popliteal artery in nine patients, to the
infrapopliteal arteries in 31 patients, and to the pedal
arteries in five patients. Successful graft revision was
possible in six patients whose grafts failed during the
postoperative period and in four patients whose
grafts failed during the follow-up period. All the suc-
cessfully revised grafts were constructed of saphe-
nous vein. No further arterial reconstructive proce-
dures were attempted in three patients whose grafts
failed during the postoperative period and in 15
patients whose grafts failed within 6 months of hos-
pital discharge. No differences were seen in the inci-
dence of preoperative risk factors, the site of the
bypass graft distal anastomosis (with or without cat-
egorization), the use of anticoagulation therapy, the
venous conduit type, or the vein score (continuous
or categorized) in the patients with postoperative
graft failure as compared with those patients whose
grafts did not fail (P > .05 for all comparisons).
Amputation was necessary in 10 patients after
graft failure in the postoperative period (seven with
graft disruption, and three with no remaining venous
conduit) and in seven patients during the follow-up
period (one with graft disruption, and six with limit-
ed remaining venous conduit). Only one patient who
underwent no further attempt at arterial reconstruc-
tion after graft failure required an amputation during
the follow-up period. Progressive tissue loss despite a
patent graft and aggressive efforts to achieve wound
healing necessitated 15 additional amputations (10 in
the postoperative period, and five during the follow-
up period). Diabetes mellitus was present in 86.7% of
these patients, extensive tissue loss in 70%, end-stage
renal disease in 42.9% (vs 18.8% of patients with
patent grafts and limb salvage; P < .05), and “bad”
run-off scores in 60% (vs 10.5% of patients with
patent grafts and limb salvage; P < .001).
Therefore, amputations were performed in 33
patients overall (15.7%)—20 in the postoperative
period, and 13 during the follow-up period—and the
indications for amputation in these 33 patients are
summarized in Table III. Again, no differences were
seen in the incidence of preoperative risk factors, the
site of the bypass graft distal anastomosis (with or
without categorization), the use of anticoagulation
therapy, the venous conduit type, or the vein score
(continuous or categorized) in patients who required
amputation as compared with those who did not (P
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Table II. Causes of graft failure in patients with
tissue loss who undergo infrainguinal vein bypass
grafting
Postoperative graft Post-discharge graft
failure (n = 19) failure (n = 27)
Graft stenosis 0 10
Graft disruption 7 1
Poor run-off 2 4
Poor vein 2 2
Technical defect 4 0
Hypercoagulable state 2 0
Perigraft infection 0 2
Inflow stenosis 0 1
Unknown 2 7
> .05 for all comparisons). The extent of the tissue
loss that prompted the infrainguinal bypass grafting
was also not significantly different (P > .05) between
patients who required amputation and those who did
not, regardless of whether the amputation was per-
formed for graft failure or progressive tissue loss,
despite a patent graft. However, there was a trend for
patients with diabetes to have a higher incidence of
amputation in the immediate postoperative period
(21.3% vs 9.0%; P = .054). Furthermore, patients
with end-stage renal disease and patients with “bad”
run-off scores had significantly higher overall inci-
dence rates of amputation (19.4% vs 6.1%; P < .05;
36.8% vs 6.4%; P < .01, respectively), and “bad” run-
off score was confirmed with multivariant analysis to
be an independent predictor of amputation.
One hundred seventy-five patients were alive and
had limb salvage at hospital discharge, and 162
patients were alive and had limb salvage 6 months after
infrainguinal vein bypass grafting for tissue loss (Table
IV). However, only 172 patients at hospital discharge
and 145 patients at 6 months had a patent bypass graft
as well. Furthermore, nine patients with limb salvage
and a patent graft had required a second procedure to
maintain or reestablish graft patency. Survival with
limb salvage at 6 months was significantly more likely
in patients who had “good” run-off scores, who
underwent treatment with long-term anticoagulation
therapy, who did not have end-stage renal disease, and
who did not have diabetes (Table V). Survival with
limb salvage and a patent bypass graft was significantly
more common only in the patients who had “good”
run-off scores (Table V). Multivarient analysis results
confirmed run-off score, anticoagulation therapy, end-
stage renal disease, and diabetes mellitus to be inde-
pendent predictors of survival, with limb salvage at 6
months and run-off score to be an independent pre-
dictor of survival with limb salvage and graft patency.
Indeed, in those patients with diabetes and “bad” run-
off scores, 57.1% had undergone amputation, only
41.2% were alive and had limb salvage, and only 29.4%
were alive, had limb salvage and had a patent bypass
graft at 6 months of follow-up.
DISCUSSION
Many factors, such as initial symptoms, degree of
occlusive disease, and availability of appropriate bypass
graft conduit influence the results of lower extremity
arterial reconstruction. Furthermore, despite overall
good results with arterial bypass grafting procedures,
outcome in an individual patient may be poor. In this
series of patients with significant infrainguinal arterial
occlusive disease with tissue loss, initial outcome after
infrainguinal venous bypass grafting was acceptable
(operative mortality rate, 8% [6% in patients who did
not have a simultaneous inflow procedure]; initial limb
salvage rate in survivors, 93.3%). However, results after
6 months of follow-up were sobering (survival rate
with limb salvage, 77.5%; and survival rate with limb
salvage and a patent graft, 69.4%). Furthermore,
bypass grafting procedures in certain subsets of
patients (eg, those with diabetes and “bad” run-off
scores) were of questionable value (survival rate with
limb salvage at 6 months, <50%). These results appear
to be inferior to other reported results of infrainguinal
vein bypass grafting for limb-threatening ischemia.
However, few studies that have examined only patients
with tissue loss who have a high incidence rate of dia-
betes mellitus and a graft patency rate of 83% and a
limb salvage rate of 86% in survivors at 6 months are
not significantly different from several other reports.
Furthermore, Nicoloff et al14 have shown that 54% of
patients who undergo infrainguinal bypass grafting for
limb-threatening ischemia require repeat procedures
during the follow-up period to maintain long-term
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Table III. Indications for amputation in patients
with tissue loss who undergo infrainguinal vein
bypass grafting
Indications No. of patients
Progressive tissue loss despite graft patency 15 (45.5%)
Graft failure without successful revision 10 (30.3%)
Graft disruption caused by graft exposure 8 (24.2%)
Table IV. Outcome in patients with tissue loss
who undergo infrainguinal vein bypass grafting
At discharge At 6 months
Survival rate with limb salvage 83.3% 77.5%
Survival rate with limb salvage 81.9% 69.4%
and patent graft
Table V. Predictors of outcome in patients with
tissue loss who undergo infrainguinal vein bypass
grafting
Survival rate with limb salvage at 6 months
Run-off score 83.2% (“good”) 52.2% (“bad”) P < .01
Anticoagulation 93.9% (yes) 52.2% (no) P < .01
therapy
End-stage renal 81.3% (no) 65% (yes) P < .05
disease
Diabetes mellitus 81.3% (no) 71.9% (yes) P < .05
Survival rate with patent graft and limb salvage at 6 months
Run-off score 75.6% (“good”) 34.8% (“bad”) P < .001
limb salvage and that only 84% of patients who were
ambulatory before the procedure remained so after-
wards. Thus, although the goal of limb salvage can be
achieved in most patients who undergo infrainguinal
bypass grafting for tissue loss, careful patient selection
is necessary to limit the number of patients who will
have limited or no benefit from these procedures.
Postoperative mortality in the current study was
primarily caused by cardiac complications. This is not
surprising considering the high incidence of coronary
artery disease in patients with severe peripheral arterial
occlusive disease.15 Unfortunately, it will likely be dif-
ficult to reduce the incidence of cardiac complications
in these patients with diffuse atherosclerosis because
previous studies from our group have shown that rou-
tine extensive cardiac evaluation does not result in bet-
ter overall postoperative survival.16 Furthermore, the
mortality rate and the incidence of cardiac complica-
tions after primary amputation are at least as high or
higher than after bypass grafting procedures,17 and
this is particularly true in patients with end-stage renal
disease (the only predictor of mortality in the study
presented here) who undergo amputation.18 In con-
trast, the avoidance of simultaneous aortic inflow pro-
cedures, particularly when a complex infrainguinal
reconstruction is necessitated, likely can reduce post-
operative mortality because we have previously
demonstrated the mortality associated with that com-
bination of procedures to be unacceptably high.19
Almost one half of the early graft failures that
resulted in amputations were caused by graft exposure
and disruption, and this problem was primarily the
result of the breakdown of pedal wounds in patients
with diabetes mellitus. Adequate tissue coverage of the
distal anastomatic site in such patients is often difficult,
and Blankensteijn et al20 have suggested that placing
the venous bypass graft in the anatomic position may
be protective in patients at risk for wound breakdown,
such as those with end-stage renal disease. This was the
technique most commonly used in the current study,
and, despite this approach, a disturbingly high number
of patients had this complication. Graft failure during
the follow-up period appeared to be primarily caused
by graft stenosis, although the exact cause of graft fail-
ure was difficult to determine in seven patients.
Surprisingly, neither the type nor the size of the venous
conduit used for these bypass grafts was found to influ-
ence graft failure, although the short length of the fol-
low-up period and the small number of patients stud-
ied likely influenced these results. Routine intraopera-
tive or early postoperative duplex ultrasound scan graft
imaging as advocated by Bandyk et al21 potentially
could have reduced this seemingly high rate of vein
graft stenosis during only 6 months of follow-up.
However, this was not used during the time period of
this study at our institution.
Progressive tissue loss, despite a patent graft, that
resulted in amputation was the most common indica-
tion for amputation in this study. Most of the patients
who required amputation for progressive tissue loss
despite a patent graft had a combination of diabetes
mellitus, extensive tissue loss, and severe, distal
infrapopliteal and pedal arterial occlusive disease.
Dietzek et al22 also noted that limb loss despite a
patent graft was more common in patients with dia-
betes, extensive tissue loss, and bypass grafts to isolat-
ed popliteal or tibial arteries. In addition, Edwards et
al23 found that all patients with end-stage renal dis-
ease who required amputation after infrainguinal
bypass grafting (90% of whom had diabetes mellitus as
well) had a patent bypass graft. Because of this, they
suggested that patients with extensive tissue loss and
end-stage renal disease were poor candidates for
infrainguinal bypass grafting and potentially might be
better served with a primary amputation, an approach
suggested by other authors as well.24 On the basis of
the results of the current study and those of Dietzek
et al,22 patients with extensive tissue loss, diabetes
mellitus, and poor run-off are also at significant risk
for amputation, despite a patent bypass graft, and this
should be strongly considered when the decision for
bypass grafting versus amputation is made.
The predictors of survival with limb salvage with
multivariant statistical analysis in this study were run-
off score, anticoagulation therapy, end-stage renal dis-
ease, and diabetes mellitus, and survival with limb sal-
vage and a patent bypass graft was predicted with run-
off score alone. As previously discussed, diabetes
mellitus is a risk factor for amputation because of pro-
gressive tissue loss despite a patent bypass graft and for
wound breakdown leading to graft disruption (which
uniformly led to amputation in the present study). In
addition, patients with end-stage renal disease have
previously been shown to have limited survival and
limb salvage after infrainguinal bypass grafting.23,24
Diabetes mellitus has not been shown to affect bypass
graft patency,25 so it is not surprising that survival with
limb salvage and graft patency was not predicted by
the presence of diabetes mellitus. In contrast, we have
recently shown in a prospective, randomized study
that anticoagulation therapy improves bypass graft
patency and limb salvage in patients at high risk for
bypass graft failure who undergo infrainguinal vein
bypass grafting.11 Thus, it is somewhat surprising that
anticoagulation therapy was not a predictor of survival
with limb salvage and graft patency at 6 months,
although this was likely affected by the retrospective
nature of the current study.
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Previous studies of the relationship between run-
off scores and subsequent bypass graft patency have
produced mixed results.9,26,27 However, poor run-off
is acknowledged as an important factor in bypass graft
patency, and both Alback et al9 and Blankensteijn et
al27 found that the run-off score obtained with the
system described by Rutherford et al13 was predictive
of long-term bypass graft patency. Those results sup-
port the finding of the present study that the use of a
modification of the system described by Rutherford et
al13 strongly predicted outcome after infrainguinal
vein bypass grafting in patients with tissue loss. The
run-off scoring system used here expanded the range
of run-off scores related to an infrapopliteal or pedal
bypass graft, which may have improved discrimination
between patients with “good” and “bad” run-off.
Regardless, details of the run-off from the site of the
planned distal anastomosis clearly have a significant
effect on outcome after infrainguinal bypass grafting.
As previously stated, the identification of patients
with limb-threatening ischemia whose conditions will
likely not benefit from lower extremity arterial recon-
struction is difficult, and because most patients do
benefit, the use of lower extremity bypass grafting has
been recommended for all patients but a selected
few.1,4 In addition, primary amputation is associated
with equal or greater morbidity and mortality rates17
and much worse function6 and long-term survival
rates,7 so that this aggressive approach has been wide-
ly accepted. However, a substantial number of
patients do not benefit from this approach, and it is
far from cost effective when early graft failure results
in an amputation.28 The results of this study and oth-
ers8,9,26,27 that examined this issue would suggest that
it is possible to identify patients with tissue loss who
have a low likelihood of survival with limb salvage and
a patent bypass graft or survival with limb salvage
alone after infrainguinal bypass grafting. Such patients
(eg, those with end-stage renal disease and extensive
tissue loss or those with diabetes mellitus and poor
runoff scores) can then be presented with appropriate
expectations for a good outcome after the bypass
grafting procedure, and appropriate consideration can
be given to a primary amputation. Alternatively, if an
infrainguinal bypass grafting procedure is performed
in such patients, adjuncts, such as anticoagulation
therapy, anatomic routing of the bypass graft, rotation
flaps to cover the distal anastomatic sites, and inten-
sive bypass graft surveillance, can be used in an
attempt to achieve the best outcome possible. A
prospective study of the potential predictors of out-
come in patients with tissue loss who undergo infrain-
guinal vein bypass grafting identified in this study and
by others is currently underway in our institution.
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Dr Stanley O. Snyder, Jr (Nashville, Tenn). Dr Seeger
and his colleagues are to be congratulated for a careful
study of a difficult group of patients that included a veter-
an smoking population, two thirds of whom were diabet-
ic and 20% of whom had end-stage renal disease.
Twenty-five patients had graft failure and did not require
amputation. Conversely, progressive tissue loss, despite a
patent graft, necessitated amputation. These data stress the
importance of attempting to define which patients indeed
require either amputation or bypass grafting as their only
alternative. Multivariant analysis results confirmed that
runoff scores, anticoagulation therapy, end-stage renal dis-
ease, and diabetes mellitus were independent predictors of
survival with limb salvage at 6 months and that only runoff
scores were predictive of survival with limb salvage and graft
patency at 6 months.
The clinical relevance of these statistics is debatable
because even the worst case scenario of diabetes mellitus and
poor runoff scores resulted in 41% limb salvage, with 29% of
the patients obtaining limb salvage and a patent graft. The
operative mortality rate for attempted limb salvage was not
much greater than that of primary amputation, and almost
every patient would opt for bypass grafting surgery when
there is a 40% to 50% chance for limb salvage. These data will
be helpful in providing appropriate education and informed
consent for patients. I am not sure that its parameters will
aide in predicting outcome for individual patients.
I have several questions, and they relate to some of the
patients who were not listed in the series. This group all
had available suitable venous tissue, and most had satisfac-
tory saphenous vein. How do you handle patients with
ischemic tissue loss and adequate runoff but inadequate
autogenous tissue?
Second, did you attempt to quantify the degree of tis-
sue loss in this group?
Third, did any patients with adequate autogenous vein
undergo primary amputation because of an inadequate
distal target vessel or inadequate runoff?
And, last, your mortality rate for combination proxi-
mal inflow procedures and infrainguinal bypass grafting
was 17%. I wonder if you have any additional thoughts
regarding primary amputation in this group of patients,
particularly if they have risk factors of end-stage renal dis-
ease and diabetes mellitus?
Thank you.
Dr James M. Seeger. Thank you, Dr Snyder, for your
discussion and insightful questions. First, we make every
effort to use autogenous tissue, including arm veins, lessor
saphenous veins, and superficial femoral veins, for infra-
geniculate bypass grafts because we have had poor results
with prosthetic infrageniculate bypass grafts. Fortunately,
with this aggressive use of alternative veins, we seldom see a
patient with adequate run-off in whom a bypass cannot be
done for limb salvage because no venous conduit is available.
Second, as mentioned in this paper, tissue loss was classified
as limited if the ischemic ulceration was less than 5 cm in
diameter or the gangrene was limited to the toes without
forefoot sepsis. No further classification of the degree of tis-
sue loss was done. Third, some patients do undergo prima-
ry amputation when absolutely no distal target vessel can be
identified after both preoperative and intraoperative, pre-
bypass arteriography, and, in selected patients, direct vessel
exploration. In a previous report from our institution by Dr
Tom Huber, primary amputation was required in only nine
of 114 patients with limb-threatening ischemia when this
approach was used. Finally, I agree with you that the group
of patients with combined aortoiliac and infrainguinal arter-
ial occlusive disease, diabetes mellitus, end-staged renal dis-
ease, and tissue loss are particularly challenging to manage.
At present, we consider the degree of tissue loss, the quality
of the infrageniculate run-off arteries, and the venous con-
duit available in deciding between attempted arterial recon-
struction and primary amputation. In addition, when
attempted arterial reconstruction seems reasonable, we stage
the inflow and outflow reconstructive procedures in all but
the most robust patients needing the most straightforward
procedures to attempt to reduce the mortality associated
with these extensive reconstructive procedures.
DISCUSSION
